Mastering Business Development and Strategic Partnerships for Emerging healthtech - A Healthtech Hub Masterclass
Description
Many healthtech founders are natural "creators"—expertly trained in science or engineering, but perhaps less familiar with the nuances of business development in a complex healthcare landscape. Building a great product is only half the journey; the other half is ensuring you have the right supporters, the right runway, and the right customer base.
Join the Cicada HealthTech Hub on June 17th for an intensive, in-person workshop designed to demystify the health sales cycle. Led by industry veteran Adam Wardell (CEO of Previsior and IGP Advisor), this session provides the frameworks you need to transition from technical development to commercial outreach.
What You Will Learn:
Stakeholder Mapping: Identify who your true stakeholders are—from hospital procurement to health executives—and tailor your value proposition to each.
The Sales Cycle: Understand how long it takes to close a deal in health, who the decision-makers are, and what evidence is required to convince them.
BD in Practice: Begin practicing introductory calls, capability presentations, and warm outreach in a supportive environment.
Metrics That Matter: Learn how to track partner interest and manage your deal funnel using CRM basics.
Who Should Attend? This workshop is designed for clinical entrepreneurs, healthtech founders, business development lead and commercial leads of health tech products, recommended for teams working towards an MVP with products at TRL2 and beyond, who have a grasp on commercialisation but need a strategic roadmap for business growth.
-----------
Don't miss this opportunity to gain valuable insights from industry experts and network with fellow health tech innovators.
Lineup
Adam Wardell, CEO, Principal Consultant Previsior
With over 25 years of experience in health, Adam is the CEO at Previsior, a boutique life sciences consultancy specialising in strategy, innovation, and commercialisation for health technologies. Spanning pharmaceuticals, biotech and digital health products, Adam has a proven track record of bringing innovation to the market, guiding and mentoring startups and established companies through the complexities of launch and scale-up. Passionate about putting Australian innovation on the global stage, Adam and his team can provide comprehensive guidance tailored to your startup’s specific needs.
Dr Kerstin Schϋtz, Director, StrandnBerg Pty Ltd
Kerstin is a highly accomplished executive and non-executive Director, recognised for her strategic leadership and ability to drive innovation translation. Kerstin has worked globally in Europe, the US and Australia in leadership roles with global pharmaceutical companies and Australian biotech companies. She works as an adviser for government commercialisation grants and has extensive knowledge in IP licensing and commercialisation having worked in the University tech transfer sector. She is experienced in working at the interface between research organisations, government programs and industry.
Mohit Gupta - Managing Director, MedTAS Pty Ltd
Leah Trend - IDE Group specialist
FAQs
- What is the Cicada HealthTech Hub?
Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses are to help bridge the gap between research and commercialisation.
Find out more about the Cicada HealthTech Hub
The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.
Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity
Apply Now
This event has passedApply Now
This event has passed
